The global Ferrous
Fumarate Market size is expected to witness potential gains in the future,
and register a significant CAGR of 15.74% over the forecast period (2019 -
2027).
Market Overview
Ferrous fumarate is the iron (II)
salt of fumaric acid used for the prevention and treatment of iron-deficiency
anemias. It is used as a dietary supplement and its administration results in
elevation of serum iron concentration, which is then assimilated into hemoglobin.
Hemoglobin carries oxygen through blood to tissues and organs. Ferrous fumarate
is used for the treatment of thalassemia, iron deficiency anemia, fatigue, and
anemia. It is also used for diagnostic assessment.
Market Dynamics
Increasing prevalence of anemia
and thalassemia is expected to boost growth of the global ferrous fumarate
market. Anemia is a condition characterized by lack of red blood cells to carry
adequate oxygen to the body's tissues. Women in the childbearing years are
highly vulnerable to anemia and iron-deficiency. Ferrous fumarate tablets can
be consumed orally and are easy to swallow. These tablets can be crushed or
chewed as they are almost tasteless. It acts as an iron supplement to treat or
prevent low blood levels of iron.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2841
However, there are many
restrictions in use of ferrous fumarate. Ferrous fumarate is not recommended to
those suffering from liver or kidney disease and porphyria. Consuming ferrous
fumarate is also associated with some side effects such as constipation, black
stool, stomach pain, abdominal bloating, flatulence, and abdominal pain.
Market Outlook
Among regions, North America is
expected to hold dominant position in the global ferrous fumarate market over
the forecast period. This is majorly attributed to presence of key
pharmaceutical companies in the region. Asia Pacific is expected to witness the
fastest growth rate in the market, owing to increasing prevalence of anemia in
the region. Moreover, significant growth in the pharmaceutical industry in
economies such as India and China is also expected to contribute to the global
market size. Key players in the market can focus on expanding their business in
emerging regions such as Africa and Middle East to enhance their market share.
Africa, South East Asia, and the Eastern Mediterranean are the regions with
high prevalence of anemia
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/ferrous-fumarate-market-2841
Key Players
Some of the manufacturers
operating in the global ferrous fumarate market include, Vifom Pharma, Ironwood
Pharmaceuticals, Galenica group, Allied Biochem Pvt. Ltd., Lonye Technology
Limited, Shreeji Industries, and Henan Sinotech Import & Export
Corporation.
Ferrous Fumarate Market - Size,
Share, Trends, and Forecast 2019 – 2027
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2841
About Coherent
Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment